Vicarious Surgical Inc.
Vicarious Surgical Inc. (RBOT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rbot · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Hold
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$10.50
Consensus
$8.75
+1490.9% upside
Low
$7.00
Median: $8.75 · Last Close: $0.55
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.52 | ↓ 5.00% |
1-day model range: $0.51–$0.53. Peak: $0.53 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RBOT · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-08-13 | Piper Sandler | Maintains | Neutral→Neutral |
| 2024-03-05 | Piper Sandler | Maintains | Neutral→Neutral |
| 2023-11-14 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2023-11-14 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
| 2023-05-31 | Canaccord Genuity | Maintains | Buy→Buy |
| 2022-07-18 | BTIG | Maintains | Buy→Buy |
| 2022-05-10 | Piper Sandler | Maintains | Neutral→Neutral |
| 2022-03-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2022-03-04 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2022-01-07 | Credit Suisse | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Vicarious Surgical Inc. (RBOT) stock. Of the recent 14 rating actions, 0 were upgrades and 3 were downgrades. 5 analysts currently cover RBOT.
Analyst Recommendation Trends
RBOT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$40M
↑ 124.6% YoY
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-8.09
EPS Next Year
$-4.07
↓ 49.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast RBOT EPS of $-8.09 for the current fiscal year, based on estimates from 1 analysts. The RBOT revenue forecast is $40M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RBOT stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RBOT price target is $8.75 (+1490.9% upside), with an analyst consensus of Hold.
The RBOT short-term stock prediction for tomorrow is $0.52 (-5.00%).
Vicarious Surgical Inc. trades on OTC under the ticker RBOT. The RBOT stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 40% of covering analysts.
Frequently asked questions
RBOT forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month RBOT price target is $8.75, with a high forecast of $10.50 and a low of $7.00. The median price target is shown in the chart above when available. This implies +1490.9% potential upside from the current price of $0.55.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.